MEDIFAST, INC.

(MED)
  Report
Delayed Nyse  -  04:00 2022-08-15 pm EDT
138.48 USD   +1.24%
08/11INSIDER BUY : Medifast
MT
08/05PUMP / DUMP #40 : This week's gainers and losers
MS
08/04DA Davidson Cuts Medifast's Price Target to $278 From $352, Reiterates Buy Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sector Update: Consumer Discretionary Stocks Back Near Even Again in Late Trade

06/01/2022 | 03:59pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BARK, INC. 5.88% 2.52 Delayed Quote.-40.28%
DARLING INGREDIENTS INC. -1.24% 76.48 Delayed Quote.10.38%
MEDIFAST, INC. 1.24% 138.48 Delayed Quote.-33.88%
MYERS INDUSTRIES, INC. 0.97% 21.97 Delayed Quote.9.80%
All news about MEDIFAST, INC.
08/11INSIDER BUY : Medifast
MT
08/05PUMP / DUMP #40 : This week's gainers and losers
MS
08/04DA Davidson Cuts Medifast's Price Target to $278 From $352, Reiterates Buy Rating
MT
08/04Jefferies Downgrades Medifast to Hold From Buy; Price Target is $150
MT
08/03MEDIFAST : Q2 Earnings Snapshot
AQ
08/03MEDIFAST INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
08/03Medifast, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Jun..
CI
08/03MEDIFAST : Announces Second Quarter 2022 Financial Results and Updated Outlook - Form 8-K
PU
08/03TRANSCRIPT : Medifast, Inc., Q2 2022 Earnings Call, Aug 03, 2022
CI
08/03Earnings Flash (MED) MEDIFAST Posts Q2 EPS $3.87
MT
More news
Analyst Recommendations on MEDIFAST, INC.
More recommendations
Financials (USD)
Sales 2022 1 570 M - -
Net income 2022 131 M - -
Net cash 2022 1,30 M - -
P/E ratio 2022 12,1x
Yield 2022 -
Capitalization 1 517 M 1 517 M -
EV / Sales 2022 0,97x
EV / Sales 2023 0,90x
Nbr of Employees 984
Free-Float 92,3%
Chart MEDIFAST, INC.
Duration : Period :
Medifast, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDIFAST, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 138,48 $
Average target price 214,00 $
Spread / Average Target 54,5%
EPS Revisions
Managers and Directors
Daniel R. Chard Executive Chairman & Chief Executive Officer
James P. Maloney Chief Financial Officer
Jeffrey J. Brown Lead Independent Director
Scott Schlackman Independent Director
Constance J. Hallquist Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MEDIFAST, INC.-33.88%1 499
ZHEJIANG NHU COMPANY LTD.-17.56%9 645
BY-HEALTH CO., LTD.-35.72%4 433
BALCHEM CORPORATION-20.42%4 310
THE SIMPLY GOOD FOODS COMPANY-17.80%3 430
BELLRING BRANDS, INC.-15.60%3 214